Online inquiry

IVTScrip™ mRNA-Human ARRDC2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25679MR)

This product GTTS-WK25679MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ARRDC2 protein. This product can be used in FGFR1 Low NME5- epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001025604.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 27106
UniProt ID Q8TBH0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRDC2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK25679MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8985MR IVTScrip™ mRNA-Human AFG3L2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AFG3L2
GTTS-WK15209MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK16336MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK25598MR IVTScrip™ mRNA-Human ARHGAP39, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP39
GTTS-WK22646MR IVTScrip™ mRNA-Human ARL6, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARL6
GTTS-WK20328MR IVTScrip™ mRNA-Human ANKRD46, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD46
GTTS-WK14633MR IVTScrip™ mRNA-Human ANKRD62, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD62
GTTS-WK20008MR IVTScrip™ mRNA-Human ANKRD20A4, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW